Lennox International’s Stock Surges Past Analyst Target: What Should Investors Do Next?
Recently, Lennox International Inc (Symbol: LII) shares traded at $625.35, exceeding the average analyst 12-month target price of $624.54. When stocks hit their target prices, analysts typically face a choice: either downgrade the valuation or raise their target based on positive changes in the company’s fundamentals. A favorable outlook for Lennox could lead to an increased target price.
A total of 13 analysts contribute to the consensus price target for Lennox. While the average stands at $624.54, opinions vary widely. Some analysts set a lower price target of $485.00, while others aim significantly higher at $684.00, leading to a standard deviation of $58.076.
Reviewing the average target provides a glimpse into the “wisdom of crowds.” Rather than relying solely on one analyst’s opinion, this figure incorporates diverse insights. As LII’s stock crosses the average target, investors should evaluate whether this price position might quickly lead to an even higher target or if it is time to reassess their investment strategy. Below is an overview of current views from analysts covering Lennox International Inc:
| Recent LII Analyst Ratings Breakdown | ||||
|---|---|---|---|---|
| » | Current | 1 Month Ago | 2 Month Ago | 3 Month Ago |
| Strong buy ratings: | 6 | 6 | 7 | 7 |
| Buy ratings: | 0 | 0 | 0 | 0 |
| Hold ratings: | 8 | 8 | 7 | 7 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 2 | 2 | 2 | 2 |
| Average rating: | 2.5 | 2.5 | 2.38 | 2.38 |
The average rating on the table ranges from 1 (Strong Buy) to 5 (Strong Sell). This analysis utilized data from Zacks Investment Research via Quandl.com. For further updates, consider checking the latest Zacks research report on LII—available for free.
Explore 10 ETFs with the Most Upside to Analyst Targets »
Additional information:
• PCP Options Chain
• CORS Options Chain
• Top 10 Hedge Funds Holding Pfizer
The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.
